Question 1

What is Quantum BioPharma?

Accepted Answer

Quantum BioPharma is a Entity.

Question 2

How often does Quantum BioPharma appear in global news?

Accepted Answer

Tracked across 6 news events drawn from 39 articles.

Question 3

When was Quantum BioPharma first tracked by Ergen?

Accepted Answer

First tracked on Jun 02, 2026.

Question 4

When was Quantum BioPharma last mentioned in news?

Accepted Answer

Last active on Aug 21, 2026.

Question 5

What is Quantum BioPharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 11 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Quantum BioPharma in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 6 events.

Question 7

What is the most recent event involving Quantum BioPharma?

Accepted Answer

Quantum BioPharma hires IR Agency (Jun 02, 2026, 6 articles).

Question 8

How did the "Quantum BioPharma hires IR Agency" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma Ltd. entered into an investor relations and consulting services agreement with Stocks.news through IR Agency LLC to increase its visibility within the financial community and attract potential investors.

Question 9

How did the "Quantum BioPharma Advances Lucid-MS to Phase 2" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma is the biopharmaceutical company developing Lucid-MS, a patented drug candidate for multiple sclerosis, and is advancing it into phase 2 clinical trials. This event highlights the company's progress and potential in addressing an unmet medical need.

Question 10

How did the "Quantum BioPharma retains FinnCom" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma is the company announcing the retention of FinnCom for marketing services. The event is a routine corporate update with no material impact on its operations or financials.

Question 11

How did the "Quantum BioPharma settles debt with shares" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma is the company settling debt by issuing shares, which reduces its liabilities but may cause minor dilution.

Question 12

How did the "Quantum BioPharma grants stock options" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma is the issuer of the stock options, a routine incentive action. The grant may modestly align management interests with shareholders but does not change the company's fundamentals.

Question 13

How did the "Cycurion Sues for Stock Manipulation" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma is referenced for its federal lawsuit alleging major financial institutions used spoofing techniques to manipulate its share price, seeking substantial damages.

Question 14

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.